Published in Hepatitis Weekly, November 12th, 2001
This disease, mostly affecting women and especially the obese, is characterized by excessive fat deposits within the liver cells. Based on a preliminary study, Mayo Clinic researchers in Rochester, Minnesota, say betaine (Cystadane) improves liver status in some people with NASH.
According to M.F. Abdelmalek and colleagues, 10 patients with NASH were prescribed twice-daily oral doses of Cystadane for 12 months, with 7 of the patients completing the full...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly